- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02635906
Reduced in Bed Rest After Coronary Arteriography or Coronary Angioplasty
Effectiveness of Reduced in Bed Rest After Coronary Arteriography or Coronary Angioplasty in Patients With Acute Coronary Syndrome: 4 Hours Versus 2 h.Clinical Trial
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This is a randomized clinical trial with a control group, based on the guidelines of the CONSORT 2010. It will be held in the cardiology unit of a public hospital in the city of São Paulo in patients admitted with Acute Coronary Syndrome undergoing coronary arteriography or coronary angioplasty by femoral arterial. Patients with hemodynamic instability will be excluded before and after the ATC, patients using oral anticoagulants presenting INR greater than 2; patients using inhibitors IIB / IIIa; patients with history of blood dyscrasias; patients undergoing invasive procedure again less than 24 hours; patients with previous diagnosis of arterial insufficiency and patients at the time of withdrawal of the introducer presenting systolic blood pressure greater than 180 mmHg and diastolic than 100 mmHg. After removing the introducer the interventional group will be in a bed rest for two hours and the control group will follow the standard nursing care for four hours. Will be assessed the following indicators: bruising, bleeding, pedis pulse and popliteal, presence of blast at the puncture site after removal of the introducer, peripheral perfusion, presence of pulsatile mass, back pain, low back pain, paresthesias, urinary retention, muscle aches, use of painkillers and erythrocyte level.
These indicators will be assessed prior to the procedure, immediately after removing the introducer, 6 hours after the removal of the introducer, 12 hours after removal of the introducer and 24 hours after removal of the introducer. Vascular outcomes will be considered the appearance of bruising, bleeding, pseudoaneurysm, arteriovenous fistula, retroperitoneal hematoma and acute arterial occlusion. Related to patient outcomes will be considered the complaints back pain, back pain, muscle pain, paresthesia and urinary retention. The assessment team will be composed of three nurses specialists in cardiology with a minimum of one year experience in patient care after the ATC. For this study will be presented by the principal investigator to the patient the study objectives, possible risks and complications and the study protocol, and if the patient agrees to participate in it will be delivered the Statement of Consent. The collected data regarding the patients included in the survey will be entered initially in a Microsoft Excel® 2010 software and later transferred to an electronic database software SPSS (Statistical Package for Social Sciences) version 20.0 and, then submitted to descriptive statistical analysis and comparison analysis between groups.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
São Paulo, Brésil, 04024-002
- Hospital São Paulo - Cardiology Unit
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- patients admitted with Acute Coronary Syndrome undergoing coronary arteriography or coronary angioplasty by femoral arterial.
Exclusion Criteria:
- patients with hemodynamic instability will be excluded before and after the ATC,
- patients using oral anticoagulants presenting INR greater than 2;
- patients using inhibitors IIB / IIIa;
- patients with history of blood dyscrasias;
- patients undergoing invasive procedure again less than 24 hours;
- patients with previous diagnosis of arterial insufficiency.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: 2 hours
after coronary arteriography or coronary angioplasty, will be removal the introducer and the patient will be in bed rest for two hours
|
BED REST FOR TWO HOURS AFTER CORONARY ARTERIOGRAPHY OR CORONARY ANGIOPLASTY
Autres noms:
|
Comparateur actif: 4 hours
after coronary arteriography or coronary angioplasty, will be removal the introducer and the patient will be in bed rest for four hours
|
BED REST FOR FOUR HOURS AFTER CORONARY ARTERIOGRAPHY OR CORONARY ANGIOPLASTY
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Back Pain, Lumber Pain and Muscle Pain
Délai: 1 hour after the bed rest
|
This outcome will be measured in relation to presence or absence.
The presence and will Assess by means of a visual analog scale of 0 to 10, whereas the smallest value as no pain and the largest value as unbearable pain.
|
1 hour after the bed rest
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Haematoma
Délai: 24 hours after the coronary angioplasty
|
This outcome will be measured in relation to presence or absence.
The presence and will measured with a millimeter ruler taking.
|
24 hours after the coronary angioplasty
|
Bleeding
Délai: 24 hours after the coronary angioplasty
|
This outcome will be measured when appear blood in a bandage or when the haemoglobin decrease more than 3g/d.
|
24 hours after the coronary angioplasty
|
Pseudoaneurysm, Arteriovenous Fistula: Retroperitoneal hematoma, Acute Arterial Occlusion:
Délai: 24 hours after the coronary angioplasty
|
This outcome will be measured in relation to presence or absence by ultrasound.
|
24 hours after the coronary angioplasty
|
Urinary retention, Paresthesia
Délai: 1 hour after the bed rest
|
This outcome will be measured in relation to presence or absence.
|
1 hour after the bed rest
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: VINICIUS B SANTOS, MASTER, Federal University of São Paulo
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 49068315.0.0000.5505
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur 2 hours
-
ProMedica Health SystemComplétéFocus : pour comparer une boisson énergisante disponible dans le commerce, des vitamines B, de la caféine seule et un placebo en termes d'efficacité sur le niveau d'énergie perçu et l'état d'éveilÉtats-Unis
-
University College, LondonMoorfields Eye Hospital NHS Foundation Trust; Targeted Genetics CorporationComplétéDégénérescence rétinienneRoyaume-Uni
-
Medifast, Inc.Complété
-
University of PennsylvaniaNational Cancer Institute (NCI); PfizerComplété
-
University of Sao Paulo General HospitalComplétéSyndrome de la vessie hyperactiveBrésil
-
Hanmi Pharmaceutical Company LimitedComplétéHypertensionCorée, République de
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityComplété
-
Sanofi Pasteur, a Sanofi CompanyImmune DesignRésilié
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityComplété